Initial real-life experience with ocrelizumab in patients with relapsing-remitting and primary progressive multiple sclerosis in Salzburg, Austria

J Feige; Tobias Moser; Z Nagy; Ferdinand Otto; Peter Wipfler; Eugen Trinka; Johann Sellner

Initial real-life experience with ocrelizumab in patients with relapsing-remitting and primary progressive multiple sclerosis in Salzburg, Austria

J Feige
, Tobias Moser
, Z Nagy
, Ferdinand Otto
, Peter Wipfler
, Eugen Trinka
, Johann Sellner

Universitätsklinik für Neurologie, neurologische Intensivmedizin und Neurorehabilitation

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	489-489
Fachzeitschrift	EUROPEAN JOURNAL OF NEUROLOGY
Jahrgang	26
Publikationsstatus	Veröffentlicht - 2019
Veranstaltung	5th Congress of the European-Academy-of-Neurology (EAN) - Oslo, NORWAY Dauer: 29 Juni 2019 → 2 Juli 2019

Dieses zitieren

@article{4b296c7e7f174f14890cce8c220bf15b,

title = "Initial real-life experience with ocrelizumab in patients with relapsing-remitting and primary progressive multiple sclerosis in Salzburg, Austria",

author = "J Feige and Tobias Moser and Z Nagy and Ferdinand Otto and Peter Wipfler and Eugen Trinka and Johann Sellner",

year = "2019",

language = "English",

volume = "26",

pages = "489--489",

journal = "EUROPEAN JOURNAL OF NEUROLOGY",

issn = "1351-5101",

publisher = "Wiley Verlag ",

note = "5th Congress of the European-Academy-of-Neurology (EAN) ; Conference date: 29-06-2019 Through 02-07-2019",

}

TY - JOUR

T1 - Initial real-life experience with ocrelizumab in patients with relapsing-remitting and primary progressive multiple sclerosis in Salzburg, Austria

AU - Feige, J

AU - Moser, Tobias

AU - Nagy, Z

AU - Otto, Ferdinand

AU - Wipfler, Peter

AU - Trinka, Eugen

AU - Sellner, Johann

PY - 2019

Y1 - 2019

M3 - Abstract (Journal)

SN - 1351-5101

VL - 26

SP - 489

EP - 489

JO - EUROPEAN JOURNAL OF NEUROLOGY

JF - EUROPEAN JOURNAL OF NEUROLOGY

T2 - 5th Congress of the European-Academy-of-Neurology (EAN)

Y2 - 29 June 2019 through 2 July 2019

ER -